<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04434430</url>
  </required_header>
  <id_info>
    <org_study_id>IndonesiaUAnes 054</org_study_id>
    <nct_id>NCT04434430</nct_id>
  </id_info>
  <brief_title>Preemptive Oral Gabapentin 600 mg in Reducing Morphine Requirement After Non Obstetric Lower Abdominal Surgery</brief_title>
  <official_title>Effectiveness of Preemptive Oral Gabapentin 600 mg on Morphine Requirement After Non Obstetric Lower Abdominal Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Indonesia University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Indonesia University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aimed to get the information about the effectiveness of preemptive oral gabapentin&#xD;
      600 mg in reducing morphine requirement after non obstetric lower abdominal surgery&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Seventy-two subjects were given informed consent before enrolling the study and randomized&#xD;
      into two groups; gabapentin and placebo. Two hours before the incision, patients were given&#xD;
      preemptive analgesia, either gabapentin or placebo. Non-invasive blood pressure monitor,&#xD;
      electrocardiogram (ECG), and pulse oxymetry were set on the subjects in the operating room.&#xD;
      General anesthesia induction was done by fentanyl 2 mcg/kg and propofol 2 mg/kg. Endotracheal&#xD;
      tube (ETT) intubation was facilitated with atracurium 0.5 mg/kg as muscle relaxant.&#xD;
      Maintenance was done by sevoflurane, oxygen, and compressed air. After surgery, patients were&#xD;
      extubated until fully conscious. Patients will be transported to recovery room&#xD;
      postoperatively. Besides paracetamol as the postoperative analgesia, we also attached patient&#xD;
      controlled analgesia (PCA) system to patients' intravenous line using continuous ambulatory&#xD;
      delivery device (CADD) contained morphine 1 mg/ml with settings 1 mg per requirement,&#xD;
      interval limit within 5 minutes, maximum dose 6 mg/hour intravenously. Cumulative morphine&#xD;
      requirement, mean visual analogue scale, and time interval after surgery to the first&#xD;
      administration of morphine will be assessed in this study.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 11, 2019</start_date>
  <completion_date type="Actual">February 29, 2020</completion_date>
  <primary_completion_date type="Actual">February 29, 2020</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Cumulative morphine requirement within 24 hours after non obstetric lower abdominal surgery</measure>
    <time_frame>24 hours after surgery</time_frame>
    <description>Measured by total consumption of morphine on patient controlled analgesia machine</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pain within 24 hours after non obstetric lower abdominal surgerysurgery: visual analogue scale</measure>
    <time_frame>24 hours after surgery</time_frame>
    <description>Measured by visual analogue scale The visual analogue scale is a measurement to assess the severity of pain. In this context, the patients will be assessed by letting them point the score on a device based on their pain experiences.&#xD;
The minimum value is 0 and the maximum is 10. The higher the score, the more severe the pain is.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain within 2 hours after non obstetric lower abdominal surgerysurgery: visual analogue scale</measure>
    <time_frame>2 hours after surgery</time_frame>
    <description>Measured by visual analogue scale The visual analogue scale is a measurement to assess the severity of pain. In this context, the patients will be assessed by letting them point the score on a device based on their pain experiences.&#xD;
The minimum value is 0 and the maximum is 10. The higher the score, the more severe the pain is.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain within 6 hours after non obstetric lower abdominal surgerysurgery: visual analogue scale</measure>
    <time_frame>6 hours after surgery</time_frame>
    <description>Measured by visual analogue scale The visual analogue scale is a measurement to assess the severity of pain. In this context, the patients will be assessed by letting them point the score on a device based on their pain experiences.&#xD;
The minimum value is 0 and the maximum is 10. The higher the score, the more severe the pain is.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain within 12 hours after non obstetric lower abdominal surgerysurgery: visual analogue scale</measure>
    <time_frame>12 hours after surgery</time_frame>
    <description>Measured by visual analogue scale The visual analogue scale is a measurement to assess the severity of pain. In this context, the patients will be assessed by letting them point the score on a device based on their pain experiences.&#xD;
The minimum value is 0 and the maximum is 10. The higher the score, the more severe the pain is.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cumulative morphine requirement within 2 hours after non obstetric lower abdominal surgery</measure>
    <time_frame>2 hours after surgery</time_frame>
    <description>Measured by total consumption of morphine on patient controlled analgesia machine</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cumulative morphine requirement within 6 hours after non obstetric lower abdominal surgery</measure>
    <time_frame>6 hours after surgery</time_frame>
    <description>Measured by total consumption of morphine on patient controlled analgesia machine</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cumulative morphine requirement within 12 hours after non obstetric lower abdominal surgery</measure>
    <time_frame>12 hours after surgery</time_frame>
    <description>Measured by total consumption of morphine on patient controlled analgesia machine</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">72</enrollment>
  <condition>Non-obstetric Lower Abdominal Surgery</condition>
  <arm_group>
    <arm_group_label>Gabapentin</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patient will receive preemptive oral gabapentin 600 mg</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Patient will receive oral placebo</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Gabapentin</intervention_name>
    <description>Oral Gabapentin 600 mg</description>
    <arm_group_label>Gabapentin</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Oral NaCl 500 mg</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria:&#xD;
&#xD;
          -  Male or female&#xD;
&#xD;
          -  Age: 18-65 years old&#xD;
&#xD;
          -  Weigh in range around 20% of the ideal body weight&#xD;
&#xD;
          -  Physical status ASA I-II&#xD;
&#xD;
          -  Scheduled for elective non-obstetric lower abdominal surgery with general anesthesia&#xD;
&#xD;
          -  Duration of surgery less than 4 hours&#xD;
&#xD;
          -  Patients who agreed to participate in this study and sign informed consent&#xD;
&#xD;
        Exclusion criteria:&#xD;
&#xD;
          -  Patients who have history of allergy or hypersensitivity to gabapentin, paracetamol,&#xD;
             morphine, or the other opioids&#xD;
&#xD;
          -  Patients who consumed analgesia and NSAID less than 12 hours before surgery&#xD;
&#xD;
          -  Patients who experienced physical trauma less than 4 days before surgery&#xD;
&#xD;
          -  Patients who have contraindications to gabapentin, morphine, and paracetamol&#xD;
&#xD;
          -  Patients who were treated with neuraxial block or peripheral nerve block before and&#xD;
             during surgery&#xD;
&#xD;
          -  Patients who have history of diabetes, severe live or renal disease&#xD;
&#xD;
          -  Patients who were treated with antihypertension, sedatives, hypnotics,&#xD;
             antidepressants, and the other drugs that have effects on nervous system&#xD;
&#xD;
          -  Patients who have psychiatric disorders&#xD;
&#xD;
          -  Patients who consumed gabapentin before perioperative period&#xD;
&#xD;
          -  Pregnant or breastfeeding patients&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Cipto Mangunkusumo Cental National Hospital</name>
      <address>
        <city>Jakarta</city>
        <state>DKI Jakarta</state>
        <zip>10430</zip>
        <country>Indonesia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Indonesia</country>
  </location_countries>
  <results_reference>
    <citation>Weiser TG, Regenbogen SE, Thompson KD, Haynes AB, Lipsitz SR, Berry WR, Gawande AA. An estimation of the global volume of surgery: a modelling strategy based on available data. Lancet. 2008 Jul 12;372(9633):139-44. doi: 10.1016/S0140-6736(08)60878-8. Epub 2008 Jun 24.</citation>
    <PMID>18582931</PMID>
  </results_reference>
  <results_reference>
    <citation>Bruce J, Quinlan J. Chronic Post Surgical Pain. Rev Pain. 2011 Sep;5(3):23-9. doi: 10.1177/204946371100500306.</citation>
    <PMID>26526062</PMID>
  </results_reference>
  <results_reference>
    <citation>Ip HY, Abrishami A, Peng PW, Wong J, Chung F. Predictors of postoperative pain and analgesic consumption: a qualitative systematic review. Anesthesiology. 2009 Sep;111(3):657-77. doi: 10.1097/ALN.0b013e3181aae87a. Review.</citation>
    <PMID>19672167</PMID>
  </results_reference>
  <results_reference>
    <citation>Shavit Y, Fridel K, Beilin B. Postoperative pain management and proinflammatory cytokines: animal and human studies. J Neuroimmune Pharmacol. 2006 Dec;1(4):443-51. Epub 2006 Sep 29. Review.</citation>
    <PMID>18040817</PMID>
  </results_reference>
  <results_reference>
    <citation>Beilin B, Shavit Y, Trabekin E, Mordashev B, Mayburd E, Zeidel A, Bessler H. The effects of postoperative pain management on immune response to surgery. Anesth Analg. 2003 Sep;97(3):822-827. doi: 10.1213/01.ANE.0000078586.82810.3B.</citation>
    <PMID>12933409</PMID>
  </results_reference>
  <results_reference>
    <citation>Lee BH, Park JO, Suk KS, Kim TH, Lee HM, Park MS, Lee SH, Park S, Lee JY, Ko SK, Moon SH. Pre-emptive and multi-modal perioperative pain management may improve quality of life in patients undergoing spinal surgery. Pain Physician. 2013 May-Jun;16(3):E217-26.</citation>
    <PMID>23703420</PMID>
  </results_reference>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>May 29, 2020</study_first_submitted>
  <study_first_submitted_qc>June 15, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">June 16, 2020</study_first_posted>
  <last_update_submitted>September 5, 2021</last_update_submitted>
  <last_update_submitted_qc>September 5, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 13, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Indonesia University</investigator_affiliation>
    <investigator_full_name>Andi Ade Wijaya Ramlan</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>preemptive analgesia</keyword>
  <keyword>gabapentin</keyword>
  <keyword>morphine</keyword>
  <keyword>lower abdominal surgery</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Gabapentin</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

